Marks Zhang
Co-founder & SVP

MegaRobo provides the CellVue® T2000, a high‑content imaging system that combines a high‑resolution CMOS sensor, digital confocal algorithms, and a high‑energy laser light source for fast, sensitive multi‑modal cell imaging. Integrated AI tools automatically recognize and segment cellular phenotypes, delivering rapid quantitative analysis for high‑throughput drug discovery and biomedical research.
Funding not disclosed

Co-founder & SVP
Researchers in life sciences, drug discovery, and related fields need high-throughput, high-resolution cell imaging to capture detailed cellular phenotypes, but existing microscopy systems are often bulky, slow, and lack integrated AI analysis, limiting experimental efficiency and data quality.
Megarobo offers the CellVue® T2000, a high-content cell imaging system that combines a high‑resolution CMOS sensor, digital confocal algorithms, and a high‑energy laser light source to deliver fast, sensitive image acquisition. The platform supports flexible configurations—including multi‑color fluorescence, brightfield, and digital phase contrast—to meet diverse assay requirements. Integrated AI‑driven recognition and segmentation tools automatically process images, reducing out‑of‑focus noise and enabling rapid quantitative analysis. A user‑friendly interface and sub‑micron precision stage streamline operation, while optional objectives and plate formats expand experimental versatility. Continuous hardware and software upgrades ensure the system remains at the forefront of imaging technology.
Primary customers are academic laboratories, biotech and pharmaceutical R&D teams, and contract research organizations that require high‑throughput, high‑content cellular imaging for drug screening, cell biology, and related biomedical research.